Tacrograf 0.25 mg Capsule is an immunosuppressant medication primarily used to prevent organ rejection in patients who have undergone kidney, liver, or heart transplants. Its active ingredient, tacrolimus, functions by suppressing the body's immune response, thereby facilitating the acceptance of the transplanted organ.Tacrograf is crucial in preventing the body's immune system from attacking transplanted organs, thereby enhancing the success rate of transplant surgeries.While its primary use is in organ transplantation, tacrolimus is also utilized in certain autoimmune conditions, such as: Severe Eczema (Atopic Dermatitis): Topical forms of tacrolimus are prescribed to manage severe eczema by modulating the immune response in the skin.